TRAP-based vectored vaccines are more immunogenic and protective than CSP-based vectors: Correlation of efficacy with long-lived memory T cells [MIM-AH-359251]

TRAP-based vectored vaccines are more immunogenic and protective than CSP-based vectors: Correlation of efficacy with long-lived memory T cells [MIM-AH-359251]

Bibliographic Details
Main Authors:	Dunachie, S, Walther, M, Keating, S, Berthoud, T, Thompson, F, Todryk, S, Carucci, D, Sinden, R, Gilbert, S, Hill, A
Format:	Journal article
Published:	2005

Similar Items

Regulatory T cells limit the cellular response to CS and TRAP encoding candidate malaria vaccines in humans [MIM-SD-8756]
by: Dunachie, S, et al.
Published: (2005)

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
by: Vuola, J, et al.
Published: (2005)

Safety, immunogenicity and efficacy studies of candidate malaria vaccines FP9 and MVA encoding ME-TRAP in Kenyan children [MIM-PB-224908]
by: Bejon, P, et al.
Published: (2005)

MIG and the regulatory cytokines IL-10 and TGF-[beta]1 correlate with malaria vaccine immunogenicity and efficacy.
by: Dunachie, S, et al.
Published: (2010)

MIG and the regulatory cytokines IL-10 and TGF-β1 correlate with malaria vaccine immunogenicity and efficacy
by: Dunachie, S, et al.
Published: (2010)

Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component.
by: Cindy Tamminga, et al.
Published: (2011-01-01)

Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein.
by: Walther, M, et al.
Published: (2006)

Uncovering the mechanisms of adenovirus vector immunogenicity
by: Dicks, M, et al.
Published: (2013)

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
by: Reyes-Sandoval, A, et al.
Published: (2008)

Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults.
by: Martha Sedegah, et al.
Published: (2011-01-01)

Immunogenicity of a pre-erythrocytic-stage malaria insert ME-trap encoded by novel simian adenoviral vectors
by: Reyes-Sandoval, A, et al.
Published: (2005)

Corrigendum to "MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines" [J. Immunol. Methods 340 (2009) 33-41] (DOI:10.1016/j.jim.2008.09.021)
by: Berthoud, T, et al.
Published: (2011)

MIG (CXCL9) is a more sensitive measure than IFN-gamma of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines (vol 340, pg 33, 2009)
by: Berthoud, T, et al.
Published: (2011)

MIG (CXCL9) is a more sensitive measure than IFN-gamma of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines.
by: Berthoud, T, et al.
Published: (2009)

Corrigendum to "MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines" [J. Immunol. Methods 340 (2009) 33-41]
by: Berthoud, T, et al.
Published: (2011)

Correction: Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
by: Reyes-Sandoval, A, et al.
Published: (2011)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
by: Dicks, M, et al.
Published: (2011)

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria.
by: Keating, S, et al.
Published: (2005)

MIG and the regulatory cytokines IL-10 and TGF-β1 correlate with malaria vaccine immunogenicity and efficacy.
by: Susanna J Dunachie, et al.
Published: (2010-09-01)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
by: Dicks, M, et al.
Published: (2012)

Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area.
by: Bejon, P, et al.
Published: (2006)

Safety and immunogenicity of the candidate malaria vaccines FP9 ME-TRAP and MVA METRAP in semi-immune adult males [MIM-OK-87312]
by: Kai, O, et al.
Published: (2005)

Tailoring a P. vivax vaccine to enhance efficacy through a combination of a CSP Virus-Like Particle Rv21 and TRAP viral vectors
by: Atcheson, E, et al.
Published: (2018)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
by: Matthew D J Dicks, et al.
Published: (2012-01-01)

Viral vectored transmission blocking vaccines against Plasmodium falciparum
by: Kapulu, M, et al.
Published: (2010)

Viral vectors as vaccine platforms: from immunogenicity to impact
by: Ewer (nee Russell), K, et al.
Published: (2016)

Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720.
by: Walther, M, et al.
Published: (2005)

The Immunogenicity of a VLP-based Malaria Vaccine Targeting CSP in Pregnant and Neonatal Mice
by: Lucie Jelínková, et al.
Published: (2023-01-01)

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
by: Eriko Padron-Regalado, et al.
Published: (2022-08-01)

Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men.
by: Imoukhuede, E, et al.
Published: (2006)

Regulatory T cells facilitate establishment of human blood stage Plasmodium falciparum infection [MIM-MW-23105]
by: Walther, M, et al.
Published: (2005)

Immunogenicity and cross-reactivity of rhesus adenoviral vectors
by: Iampietro, M, et al.
Published: (2018)

Nonviral vector system for cancer immunogene therapy
by: Wen Nie, et al.
Published: (2022-06-01)

Viral vector delivery of Env trimer immunogens
by: Parks CL, et al.
Published: (2012-09-01)

Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter
by: Alharbi, N, et al.
Published: (2015)

Viral vector vaccines make memory T cells against malaria.
by: Reyes-Sandoval, A, et al.
Published: (2007)

Viral vectored transmission blocking vaccines against <it>Plasmodium falciparum</it>
by: Sinden Robert E, et al.
Published: (2010-10-01)

Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naive and malaria-exposed individuals.
by: Bejon, P, et al.
Published: (2006)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
by: Warimwe, G, et al.
Published: (2013)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
by: Marta Ulaszewska, et al.
Published: (2023-01-01)